loader image

Hematology Oncology

Immunotherapy With Keytruda (Pembolizumab)

Immunotherapy with Keytruda (Pembolizumab) is an innovative cancer treatment designed to empower the immune system to recognize and destroy cancer cells. Unlike traditional treatments, Keytruda targets immune checkpoints, enhancing the body’s ability to detect hidden malignancies. Turkey has become a leading destination for this advanced therapy, with renowned oncology clinics, expert specialists, and cost-effective options for international patients.

What is Immunotherapy?

Immunotherapy represents a revolutionary shift in cancer treatment, focusing on the body’s immune system as the primary tool for combating disease.

How Immunotherapy Strengthens the Immune System

Immunotherapy enhances the immune system’s natural defenses by:

  • Activating T-cells to attack cancer cells.
  • Blocking immune checkpoints that cancer cells use to hide.
  • Encouraging long-term immune memory to prevent recurrence.

Applications in Cancer Treatment

Immunotherapy is particularly effective in treating:

  • Lung Cancer
  • Melanoma
  • Head and Neck Cancers
  • Bladder Cancer

Key Differences from Chemotherapy and Radiotherapy

  • Targeted Action: Unlike chemotherapy, which affects all rapidly dividing cells, Keytruda focuses solely on cancer cells.
  • Fewer Side Effects: Patients experience reduced nausea, fatigue, and hair loss compared to traditional therapies.
  • Sustainability: Immunotherapy offers long-lasting benefits by training the immune system to continue fighting cancer post-treatment.

How Does Keytruda Work?

Keytruda, also known as Pembolizumab, is a monoclonal antibody that works by targeting a protein called PD-1 (Programmed Death-1) found on T-cells. This mechanism prevents cancer cells from evading the immune system, allowing the body to recognize and destroy them effectively.

Mechanism of Action: Targeting Immune Checkpoints

Cancer cells often exploit the PD-1/PD-L1 pathway to suppress immune responses. Keytruda blocks this interaction, unleashing T-cells to attack tumors. This unique action makes it highly effective for cancers that express PD-L1 proteins, such as:
  • Non-Small Cell Lung Cancer (NSCLC)
  • Melanoma
  • Renal Cell Carcinoma

Types of Cancers Treated with Keytruda

Keytruda has received FDA approval for treating multiple cancers, including:
  1. Lung Cancer: Effective in NSCLC, particularly in advanced or metastatic stages.
  2. Melanoma: Provides an alternative for patients unresponsive to traditional therapies.
  3. Head and Neck Cancer: Targets advanced squamous cell carcinoma.
  4. Bladder Cancer: Useful in cases where chemotherapy fails.
  5. Hodgkin Lymphoma: Offers new hope for relapsed or refractory patients.

Advantages Over Conventional Treatments

Keytruda surpasses traditional cancer therapies with its ability to:
  • Tailor Treatment: Personalized for patients based on PD-L1 expression levels.
  • Minimize Damage: Reduces harm to healthy cells compared to chemotherapy or radiation.
  • Sustain Benefits: Creates immune memory for long-term protection against cancer recurrence.

Benefits of Keytruda in Cancer Therapy

Keytruda provides life-changing benefits, offering hope for patients with advanced-stage cancers.

Detecting and Eliminating Hidden Cancer Cells

Unlike conventional therapies that target visible tumors, Keytruda activates the immune system to detect and eliminate hidden cancer cells that might otherwise escape treatment.

Reduced Side Effects Compared to Traditional Treatments

Patients report fewer and less severe side effects, such as:

  • Mild fatigue
  • Rash or itching
  • Occasional fever

Improved Survival Rates for Certain Cancers

Clinical trials have shown that Keytruda significantly improves survival rates, especially in lung and melanoma cancers.

Immunotherapy With Keytruda (Pembolizumab)
Immunotherapy With Keytruda (Pembolizumab)

Why Choose Turkey for Immunotherapy?

Turkey has emerged as a leading destination for advanced cancer treatments, including immunotherapy with Keytruda. With cutting-edge technology, expert oncologists, and affordable care, the country provides comprehensive solutions for international patients.

Advanced Oncology Clinics in Istanbul

Istanbul is home to world-renowned oncology centers equipped with the latest in cancer treatment technologies.

  • Key Features:
    • State-of-the-art diagnostic tools, such as tumor marker tests.
    • Specialized teams for immunotherapy and checkpoint inhibitor treatments.
    • Access to clinical trials and emerging therapies.

Expertise in Immune Checkpoint Inhibitors

Turkey’s oncologists have extensive experience in administering Pembolizumab therapy, ensuring precise and effective treatment tailored to each patient.

Affordable Treatment Packages for International Patients

  • Lower Costs: Treatments in Turkey cost significantly less than in the U.S. or Europe, with no compromise on quality.
  • Comprehensive Packages: Includes initial consultation, therapy, accommodation, and follow-ups.

Treatment Costs of Keytruda in Turkey

Factors Influencing Cost

  • Dosage Requirements: Depending on the patient’s weight and cancer stage.
  • Duration of Treatment: Some cancers require multiple cycles of Keytruda.
  • Facility Type: Prices may vary between private and public hospitals.

Price Comparison: Turkey vs. Global Options

  • Turkey: Approx. $5,000–$8,000 per cycle.
  • U.S.: Around $10,000–$15,000 per cycle.
  • Europe: Costs range between €8,000–€12,000 per cycle.

What’s Included in Comprehensive Packages?

  • Pre-treatment tests and diagnostics.
  • All immunotherapy sessions.
  • Post-treatment monitoring and support.

Post-Treatment Care and Follow-up

After completing immunotherapy with Keytruda, maintaining overall health and monitoring progress is essential.

Monitoring Immune Response

Regular blood tests and imaging help track the effectiveness of the treatment and ensure early detection of any relapses.

Long-term Benefits of Immunotherapy

Keytruda not only fights existing cancer but also provides long-term protection by boosting immune memory, reducing the chances of recurrence.

Support Services for International Patients

  • Translation assistance for non-Turkish speakers.
  • Dedicated care coordinators to manage travel, accommodation, and appointment

Thoughts on Keytruda Immunotherapy in Turkey

Immunotherapy with Keytruda (Pembolizumab) represents a breakthrough in cancer care, offering a targeted approach with fewer side effects. Turkey’s combination of advanced oncology services, expert care, and cost-effective options makes it an excellent choice for patients worldwide.

Choose Fibohealth to start your journey to recovery with confidence!

Frequently Asked Questions

What Cancers Respond Best to Keytruda?

  • Lung cancer (Non-Small Cell Lung Cancer)
  • Melanoma
  • Head and neck cancers
  • Bladder cancer

Are There Risks or Side Effects With Immunotherapy?

Keytruda is generally well-tolerated, but some patients may experience:
  • Fatigue
  • Mild rash or itching
  • Immune-related reactions, such as inflammation of the liver or thyroid.

How Long Does a Treatment Cycle Take?

Each Keytruda infusion takes approximately 30–60 minutes, with cycles scheduled every 3–6 weeks, depending on the treatment plan.

The indicated treatments are performed in the hospitals that we have agreements with.

Patient Guide


Steps To Follow


Before You Travel


Accommodation


Transportation


Language Interpreter Services


    Get A Free Quote

    Please fill out the form accurately and completely

    Disease*

    When Was The Diagnosis Made?*

    Click to Chat!